One Life vs Many: The deadly math of medicineThe brutal logic behind denying an experimental drug

From the show

Colliding Truths

A controversial 2014 pharma decision reveals the dark utilitarian choices inherent in modern healthcare. When seven-year-old Josh Hardy needed an unapproved antiviral to survive, Chimerix said no. Granting compassionate use risked skewing clinical trial data, potentially derailing FDA approval and harming thousands of future patients. This case exposes the heartbreaking tension between protecting the greater good and fighting for a single desperate patient.